Top Page
Regional Health Properties
(OTC:RHEP)
Regional Health Properties (RHEP) vs. SPDR S&P 500 ETF (SPY)
Regional Health Properties Business Overview & Revenue Model
Regional Health Properties Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.51M | 18.34M | 17.16M | 35.92M | 26.69M | 17.58M |
| Gross Profit | 8.14M | 8.30M | 8.00M | 9.98M | 10.31M | 10.35M |
| EBITDA | 1.72M | 2.22M | 1.45M | -1.93M | 4.08M | 5.07M |
| Net Income | -3.52M | -3.22M | -3.89M | -6.87M | -1.18M | -688.00K |
Balance Sheet | ||||||
| Total Assets | 59.28M | 60.47M | 62.18M | 68.58M | 105.70M | 108.03M |
| Cash, Cash Equivalents and Short-Term Investments | 3.06M | 582.00K | 953.00K | 843.00K | 6.79M | 4.19M |
| Total Debt | 51.51M | 43.96M | 45.68M | 55.40M | 84.94M | 90.32M |
| Total Liabilities | 63.44M | 63.38M | 62.00M | 64.86M | 95.30M | 96.92M |
| Stockholders Equity | -4.16M | -2.92M | 185.00K | 3.72M | 10.40M | 11.10M |
Cash Flow | ||||||
| Free Cash Flow | 1.04M | 1.41M | 2.75M | -3.88M | 4.77M | 845.00K |
| Operating Cash Flow | 1.58M | 1.94M | 3.71M | -3.60M | 4.89M | 1.29M |
| Investing Cash Flow | -540.00K | -530.00K | -958.00K | -281.00K | -123.00K | -450.00K |
| Financing Cash Flow | -1.96M | -2.13M | -2.48M | -2.06M | -2.42M | -1.39M |
Regional Health Properties Technical Analysis
Regional Health Properties Risk Analysis
Regional Health Properties Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | $838.82M | 31.32 | 11.44% | ― | 30.58% | 24.86% | |
69 Neutral | $1.73B | 16.61 | 10.65% | 2.21% | 25.19% | 13.44% | |
56 Neutral | $495.24M | ― | -53.33% | ― | 31.37% | 34.94% | |
51 Neutral | $7.81B | -0.22 | -40.01% | 2.29% | 21.48% | -2.11% | |
46 Neutral | $1.84B | ― | -108.91% | ― | 3.99% | -14.74% | |
45 Neutral | $7.29M | ― | ― | 59.17% | -56.62% | ||
41 Neutral | $8.29M | ― | -951.52% | ― | -0.70% | -2.38% |
Regional Health Properties Corporate Events
On August 14, 2025, Regional Health Properties, Inc. completed its merger with SunLink Health Systems, Inc., integrating SunLink’s pharmacy and healthcare services with Regional’s real estate platform. This merger, which resulted in the issuance of approximately 1,595,400 shares of Regional common stock and 1,408,120 shares of Regional Series D preferred stock, aims to create a vertically integrated company poised for growth and improved efficiency. The leadership team of the newly combined company includes Brent S. Morrison as President and CEO, with a board of directors composed of members from both Regional and SunLink.
On August 4, 2025, Regional Health Properties and SunLink Health Systems announced that their shareholders approved the merger of SunLink into Regional, with Regional as the surviving entity. The merger, subject to customary closing conditions, involves the issuance of Regional’s common stock and Series D Preferred Stock as part of the merger consideration, marking a significant step in the integration of the two companies.
On July 30, 2025, Regional Health Properties, Inc. entered into a binding asset purchase agreement to sell Coosa Valley Health and Rehab to Coosa Valley SNF Realty LLC for $10.6 million, subject to a 45-day due diligence period. Additionally, Regional Health Properties and SunLink Health Systems, Inc. are planning a proposed merger, which will be submitted to shareholders for consideration, with important documents filed with the SEC for investor review.
On July 29, 2025, Regional Health Properties, Inc. held a special meeting to discuss a proposed merger with SunLink Health Systems, Inc. The meeting was adjourned to solicit additional votes for the merger and share issuance proposals, with plans to reconvene on August 4, 2025. This merger, if approved, would see SunLink merging into Regional, potentially impacting stakeholders by consolidating operations under Regional’s management.
On July 28, 2025, Regional Health Properties, Inc. announced a proposed merger with SunLink Health Systems, Inc., urging shareholders to vote in favor. The merger is expected to bring significant benefits, including improved capital access, enhanced management expertise, and potential for increased shareholder value. Despite opposition from certain shareholders with interests in Series B preferred stock, the merger is positioned as advantageous for all shareholders, aiming to improve the company’s financial standing and market presence.
On July 24, 2025, Regional Health Properties, Inc. released a presentation and a letter to investors. The release of these documents may impact the company’s operations and provide insights into its strategic direction, potentially affecting stakeholders.
Regional Health Properties, Inc. and SunLink Health Systems, Inc. have entered into a merger agreement, with Regional set to survive the merger. Despite receiving two unsolicited acquisition proposals from third parties, Regional’s board determined that these offers did not provide superior value compared to the merger with SunLink. Additionally, a class action lawsuit was filed against Regional concerning the merger, but the company believes the claims are without merit and is proceeding with the merger to ensure deal certainty and shareholder value.
On April 14, 2025, Regional Health Properties and SunLink Health Systems entered into a merger agreement, with Regional set to be the surviving corporation. Due to outstanding shareholder approvals, the termination date for the merger was extended from June 30, 2025, to August 11, 2025, allowing more time for the necessary approvals to be obtained.
Regional Health Properties, Inc. has faced a decision by the NYSE American LLC to delist its common stock and Series A Preferred Shares due to non-compliance with listing standards, with the delisting process initiated on June 11, 2025. Despite this setback, Regional remains committed to a proposed merger with SunLink Health Systems, Inc., although there is no guarantee that any securities issued in the merger will be approved by a national securities exchange.